For Benefits Providers
Insurance Companies & Benefits Providers
Reducing The Costs of Mental Illness
Introducing pharmacogenetics in insurance plans will reduce the costs associated with mental illness. Integrating pharmacogenetic testing as a covered benefit enables insurers to enhance patient outcomes while achieving significant cost savings.
Pharmacogenomics can reduce direct and indirect costs associated with mental illness.
Key Benefits for Insurers
Cost Reduction Through Lower Morbidity
Pharmacogenetic testing puts plan members on the right drug sooner, thus preventing absenteeism and disability.
Improved Productivity
An ineffective antidepressant or one that causes side effects can result in an employee's productivity to be reduced. Pharmacogenetic testing can identify effective medications based on genetic profiles, resulting in improved treatment outcomes and boosting productivity.
Efficient Drug Spending
Prevent unnecessary spending on ineffective treatments and reduce overall drug costs by targeting optimal health outcomes.
Privacy & Security
Canadian-Based Operations
Company based in Toronto with patient privacy protected under Canadian law.
Data Protection
Information not shared with third parties (insurers). Coverage decisions cannot be based on genetic testing.
Anti-Discrimination Act
Protected under Canada’s Genetic Non-Discrimination Act.
Patient Control
Results shared only with consenting individuals.
Interested in Adding Pharmacogenetics to Your Plan?
Contact us to learn how pharmacogenetic testing can benefit your organization and members.